Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pacific Health Care Organization (PFHO) Common Equity (2016 - 2025)

Historic Common Equity for Pacific Health Care Organization (PFHO) over the last 17 years, with Q3 2025 value amounting to $12.8 million.

  • Pacific Health Care Organization's Common Equity rose 1271.42% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 1271.42%. This contributed to the annual value of $11.7 million for FY2024, which is 817.86% up from last year.
  • Per Pacific Health Care Organization's latest filing, its Common Equity stood at $12.8 million for Q3 2025, which was up 1271.42% from $12.6 million recorded in Q2 2025.
  • In the past 5 years, Pacific Health Care Organization's Common Equity ranged from a high of $12.8 million in Q3 2025 and a low of $10.3 million during Q1 2021
  • Its 5-year average for Common Equity is $11.2 million, with a median of $11.1 million in 2022.
  • In the last 5 years, Pacific Health Care Organization's Common Equity plummeted by 713.12% in 2023 and then soared by 1271.42% in 2025.
  • Over the past 5 years, Pacific Health Care Organization's Common Equity (Quarter) stood at $10.8 million in 2021, then rose by 4.55% to $11.3 million in 2022, then fell by 4.54% to $10.8 million in 2023, then rose by 8.18% to $11.7 million in 2024, then increased by 9.86% to $12.8 million in 2025.
  • Its Common Equity was $12.8 million in Q3 2025, compared to $12.6 million in Q2 2025 and $12.0 million in Q1 2025.